Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ IRBESARTAN HCT | 300MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124612 |
| TEVA-IRBESARTAN HCTZ | 300MG 12.5MG | TABLET | Resolved | 2024-04-11 | 2024-06-29 | 224895 |
| IRBESARTAN-HCTZ | 300MG 12.5MG | TABLET | Resolved | 2020-10-09 | 2020-10-30 | 126054 |
| IRBESARTAN HCT | 300MG 25MG | TABLET | Resolved | 2020-10-16 | 2021-02-12 | 126606 |
| SANDOZ IRBESARTAN HCT | 300MG 25MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124617 |
| SANDOZ IRBESARTAN HCT | 300MG 25MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124621 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2021-06-10 | 2021-09-10 | 140681 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2023-11-03 | 2024-03-07 | 209122 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Actual shortage | 2024-04-11 | 2024-05-23 | 224898 |
| AVAPRO | 300MG | TABLET | Resolved | 2019-02-08 | 2019-03-29 | 75171 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2017-08-24 | 2017-10-03 | 20271 |
| VAN-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58392 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| AVAPRO | 75MG | TABLET | To be discontinued | 2024-05-31 | 2024-05-31 | 229306 |
| TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |
| MYLAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-04-04 | 2018-08-01 | 44870 |
| VAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-08-17 | 2018-08-17 | 58386 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |